Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung-Cheng Lai

Showing results (51-60 of 128) with videos related to

Pageof 13
Sort By:
The American Journal of Pathology|January 7, 2012
ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcomeYu-Chi Wang, Yi-Te Yo, Hsin-Yi Lee, et al.
International Journal of Molecular Sciences|July 9, 2022
BHLHE22 Expression Is Associated with a Proinflammatory Immune Microenvironment and Confers a Favorable Prognosis in Endometrial CancerDarmawi, Lin-Yu Chen, Po-Hsuan Su, et al.
International Journal of Oncology|September 2, 2014
Epigenetic silencing of ARNTL, a circadian gene and potential tumor suppressor in ovarian cancerChia-Ming Yeh, Jacqueline Shay, Ting-Chuan Zeng, et al.
International Journal of Cancer|October 23, 2004
Genetic polymorphism of the interferon-gamma gene in cervical carcinogenesisHung-Cheng Lai, Cheng-Chang Chang, Ya-Wen Lin, et al.
Communications Biology|August 3, 2019
The role of GRHL2 and epigenetic remodeling in epithelial-mesenchymal plasticity in ovarian cancer cellsVin Yee Chung, Tuan Zea Tan, Jieru Ye, et al.
Oncotarget|September 9, 2017
An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patientsPing-Ying Chang, Yu-Ping Liao, Hui-Chen Wang, et al.
Plos One|July 29, 2017
Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancerTai-Kuang Chao, Tien-Shuo Huang, Yu-Ping Liao, et al.
Taiwanese Journal of Obstetrics & Gynecology|April 10, 2012
Robotic surgery in complicated gynecologic diseases: experience of Tri-Service General Hospital in TaiwanShun-Jen Tan, Chi-Kung Lin, Pei-Te Fu, et al.
American Journal of Obstetrics and Gynecology|September 14, 2010
Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear resultsCuei Jyuan Lin, Hung-Cheng Lai, Kai Hung Wang, et al.
International Journal of Cancer|August 2, 2013
Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cellsPei-Ning Yu, Ming-De Yan, Hung-Cheng Lai, et al.
Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
The American Journal of Pathology|January 7, 2012
ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcomeYu-Chi Wang, Yi-Te Yo, Hsin-Yi Lee, et al.
International Journal of Molecular Sciences|July 9, 2022
BHLHE22 Expression Is Associated with a Proinflammatory Immune Microenvironment and Confers a Favorable Prognosis in Endometrial CancerDarmawi, Lin-Yu Chen, Po-Hsuan Su, et al.
International Journal of Oncology|September 2, 2014
Epigenetic silencing of ARNTL, a circadian gene and potential tumor suppressor in ovarian cancerChia-Ming Yeh, Jacqueline Shay, Ting-Chuan Zeng, et al.
International Journal of Cancer|October 23, 2004
Genetic polymorphism of the interferon-gamma gene in cervical carcinogenesisHung-Cheng Lai, Cheng-Chang Chang, Ya-Wen Lin, et al.
Communications Biology|August 3, 2019
The role of GRHL2 and epigenetic remodeling in epithelial-mesenchymal plasticity in ovarian cancer cellsVin Yee Chung, Tuan Zea Tan, Jieru Ye, et al.
Oncotarget|September 9, 2017
An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patientsPing-Ying Chang, Yu-Ping Liao, Hui-Chen Wang, et al.
Plos One|July 29, 2017
Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancerTai-Kuang Chao, Tien-Shuo Huang, Yu-Ping Liao, et al.
Taiwanese Journal of Obstetrics & Gynecology|April 10, 2012
Robotic surgery in complicated gynecologic diseases: experience of Tri-Service General Hospital in TaiwanShun-Jen Tan, Chi-Kung Lin, Pei-Te Fu, et al.
American Journal of Obstetrics and Gynecology|September 14, 2010
Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear resultsCuei Jyuan Lin, Hung-Cheng Lai, Kai Hung Wang, et al.
International Journal of Cancer|August 2, 2013
Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cellsPei-Ning Yu, Ming-De Yan, Hung-Cheng Lai, et al.
Pageof 13